- Mechanism
- Stimulates T-cell maturation and cytokine production
- Typical research dose
- 0.8-1.6 mg twice weekly subcutaneous
- Route
- subcutaneous
- Half-life
- ~2 hours
- Legal status
- Research Only (US) / Approved Internationally
Overview
Thymosin Alpha-1 is a highly conserved, naturally occurring 28-amino acid peptide originally isolated from the thymus gland. This profound immune-modulating compound functions as a critical regulator of the immune system, enhancing T-cell maturation and stimulating the production of vital cytokines. Research indicates that Thymosin Alpha-1 benefits extend to treating viral infections, sepsis, and certain cancers by restoring immune homeostasis Dominari et al., 2020. Understanding the Thymosin Alpha-1 peptide matters because it offers a targeted approach to combating immune dysfunction without the severe immunosuppressive risks associated with traditional therapies.
Potential Benefits
- Viral Infection Management: Clinical trials demonstrate efficacy in treating chronic Hepatitis B and HIV-1 by enhancing cellular immune responses Matteucci et al., 2017.
- Sepsis Survival Improvement: Research shows it significantly improves survival rates in sepsis patients by modulating the inflammatory cascade Pei et al., 2018.
- Cancer Immunotherapy Support: Studies indicate it reverses tumor-associated macrophage polarization, enhancing the body's natural anti-tumor defenses Wei et al., 2022.
- Respiratory Disease Exacerbation Prevention: Meta-analyses confirm it reduces acute exacerbations in chronic obstructive pulmonary disease (COPD) when combined with routine care Cao et al., 2024.
- Severe Pancreatitis Protection: Clinical data reveals it alleviates inflammation and prevents secondary pancreatic infections following acute necrotizing pancreatitis Tian et al., 2025.
- Age-Related Immune Decline Reversal: Emerging evidence suggests it counteracts immunosenescence, restoring youthful cellular immunity in aging populations Simonova et al., 2025.
Where to Buy Thymosin Alpha-1
Research compound. Thymosin Alpha-1 is a research chemical, typically not FDA-approved for human consumption. Sale or use for human consumption may be illegal in your jurisdiction.
No compensation. PeptideStack does not endorse, verify, or receive compensation from any vendor. No affiliate or referral relationships.
Verify third-party COAs and consult a qualified healthcare provider before using any compound.
Side Effects
Common side effects:
- Injection site redness, pain, or irritation
- Mild fatigue or transient lethargy
- Temporary muscle aches or joint pain
- Low-grade fever or chills
Rare or serious side effects:
- Allergic reactions or anaphylaxis
- Autoimmune flare-ups in susceptible individuals
- Unintended immune overstimulation or cytokine release
Thymosin Alpha-1 is not FDA-approved and is intended for research purposes only. Consult a qualified healthcare provider before use.
Mechanism of Action
T-cell maturation and differentiation represent the primary mechanisms through which the Thymosin Alpha-1 peptide exerts its effects. It binds to specific receptors on immune cells, triggering intracellular signaling pathways like Toll-like receptor 9 (TLR9) and MyD88. This interaction stimulates the production of essential cytokines, including interferon-gamma and interleukin-2, which are crucial for mounting robust antiviral and anti-tumor responses Ancell et al., 2001.
Macrophage polarization and immune homeostasis are also heavily influenced by this peptide. It actively shifts tumor-associated macrophages from a pro-tumor (M2) state to an anti-tumor (M1) state during efferocytosis Wei et al., 2022. Furthermore, it prevents immune exhaustion by upregulating major histocompatibility complex (MHC) class I expression, ensuring the immune system remains vigilant against pathogens and malignant cells.
Origin & History
Discovery and isolation of Thymosin Alpha-1 occurred in the late 1970s when researchers extracted it from fraction 5 of the bovine thymus gland. It was quickly identified as a highly conserved 28-amino acid peptide, identical in humans and many other mammals. Early phenotypic drug discovery efforts highlighted its potential to restore immune function in immunodeficient models Garaci et al., 2024.
Clinical development and regulatory milestones have since expanded its applications globally. While it remains a research-only chemical in the United States, it has been approved under the trade name Zadaxin in over 30 countries for treating Hepatitis B and Hepatitis C. Extensive clinical trials continue to explore its efficacy in conditions ranging from hepatocellular carcinoma to acute respiratory distress syndrome NCT00082082.